XTLB · Insider Trading
XTL Biopharmaceuticals Ltd. American Depositary Shares
Every open-market purchase and sale reported by XTLB officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2008-12-03 | Joseph Edelman | 10%+ Owner | Sell | −120,151,110 | −$17.42M |
| 2008-11-04 | Michael S Weiss | Director | MIXED | +416,667 deriv. | — |
| 2008-11-04 | Ben-Zion Weiner | Director | A | +300,000 deriv. | — |
| 2008-06-19 | Michael Cho | 10%+ Owner | Buy | +255,000 | +$823.65K |
| 2008-06-11 | PERCEPTIVE ADVISORS LLC | 10%+ Owner | Buy | +2,168,000 | +$7.11M |
| 2008-06-06 | Michael Cho | 10%+ Owner | Buy | +2,128,650 | +$6.44M |
| 2008-05-06 | PERCEPTIVE ADVISORS LLC | 10%+ Owner | Buy | +775,000 | +$2.94M |
| 2008-05-02 | Joseph Edelman | 10%+ Owner | Buy | +1,788,050 | +$6.46M |
| 2008-04-16 | Michael Cho | 10%+ Owner | Buy | +500,000 | +$1.79M |
| 2008-04-04 | Michael Cho | 10%+ Owner | Buy | +1,505,000 | +$4.76M |
| 2008-04-02 | Michael Cho | 10%+ Owner | Buy | +125,000 | +$362.30K |
| 2008-03-20 | Joseph Edelman | 10%+ Owner | Buy | +3,336,100 | +$10.94M |
| 2008-03-19 | Michael Cho | 10%+ Owner | Buy | +13,423,900 | +$43.98M |
| 2008-03-19 | Michael Cho | 10%+ Owner | Buy | +10,327,300 | +$38.93M |
| 2008-03-10 | PERCEPTIVE ADVISORS LLC | 10%+ Owner | Buy | +4,903,500 | +$19.40M |
| 2008-02-29 | Michael Cho | 10%+ Owner | Buy | +550,000 | +$2.21M |
| 2008-02-28 | PERCEPTIVE ADVISORS LLC | 10%+ Owner | Buy | +2,315,900 | +$9.06M |
| 2008-02-28 | Michael Cho | 10%+ Owner | Buy | +10,240,000 | +$40.08M |
| 2008-02-22 | Michael Cho | 10%+ Owner | Buy | +5,000 | +$19.20K |
| 2008-02-19 | Michael Cho | 10%+ Owner | Buy | +30,000 | +$114.25K |
| 2008-02-08 | Michael Cho | 10%+ Owner | Buy | +1,810,000 | +$6.70M |
| 2008-02-06 | Joseph Edelman | 10%+ Owner | Buy | +4,710,000 | +$18.13M |
| 2008-02-05 | Scott Bradley | 10%+ Owner | Buy | +7,970,000 | +$28.39M |
| 2008-02-01 | Michael Cho | 10%+ Owner | Buy | +1,250,000 | +$4.04M |
| 2008-01-30 | Michael Cho | 10%+ Owner | Buy | +3,900,000 | +$12.54M |
| 2008-01-29 | Michael Cho | 10%+ Owner | Buy | +1,000,000 | +$3.24M |
| 2008-01-28 | Joseph Edelman | 10%+ Owner | Buy | +3,192,850 | +$9.38M |
| 2008-01-25 | Joseph Edelman | 10%+ Owner | Buy | +10,471,550 | +$32.38M |
| 2008-01-18 | Michael Cho | 10%+ Owner | Buy | +7,065,000 | +$21.90M |
| 2008-01-15 | Joseph Edelman | 10%+ Owner | Buy | +4,210,000 | +$14.32M |
| 2008-01-11 | Scott Bradley | 10%+ Owner | Buy | +21,555,000 | +$69.09M |
| 2008-01-08 | Michael Cho | 10%+ Owner | Buy | +2,250,000 | +$7.02M |
| 2008-01-04 | PERCEPTIVE ADVISORS LLC | 10%+ Owner | Buy | +6,500,000 | +$18.79M |
| 2008-01-02 | Michael Cho | 10%+ Owner | Buy | +9,750,000 | +$26.50M |
| 2007-12-31 | Michael Cho | 10%+ Owner | Buy | +1,500,000 | +$3.89M |
| 2007-08-21 | Ron Bentsur | CEO | Buy | +15,279 | +$19.86K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the XTLB quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.